Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-021 with reference bevacizumab

Overview of attention for article published in BMC Cancer, February 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-021 with reference bevacizumab https://t.co/8idM7Dq6ke #lungcancer #oncology https://t.co/2O9xn2u6nt

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.